Zimmer Partners’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.5M Sell
140,000
-162,500
-54% -$5.97M 0.11% 99
2025
Q4
$11.6M Hold
302,500
0.31% 60
2025
Q3
$4.15M Buy
302,500
+65,000
+27% +$763K 0.09% 108
2025
Q2
$3.07M Sell
237,500
-1,868,813
-89% -$19.4M 0.07% 123
2025
Q1
$23.7M Buy
2,106,313
+159,084
+8% +$2.09M 0.45% 48
2024
Q4
$25.5M Sell
1,947,229
-382,300
-16% -$9.81M 0.44% 41
2024
Q3
$93.1M Buy
2,329,529
+1,529,529
+191% +$55.6M 1.7% 16
2024
Q2
$23.6M Buy
+800,000
New +$21.8M 0.44% 44

Other funds holding PACS

Zimmer Partners's PACS Position: Q1 2026 in Review

Zimmer Partners reduced its PACS Group (PACS) stake by 54% in Q1 2026, selling an estimated $5.97M and leaving 140,000 shares worth $4.5M. The position accounts for 0.11% of the portfolio, ranked #99.

Zimmer Partners first reported a position in PACS in Q2 2024 and has held it in 8 quarters since. The position peaked at $93.1M in Q3 2024. 215 funds tracked by Wall St. Rank hold PACS as of Q1 2026.

  • Zimmer Partners held 140,000 shares of PACS Group worth $4.5M as of Q1 2026.
  • Zimmer Partners sold 162,500 PACS Group shares in Q1 2026, an estimated $5.97M.
  • PACS Group made up 0.11% of Zimmer Partners's portfolio in Q1 2026, its #99 holding.
  • Zimmer Partners first reported a position in PACS Group in Q2 2024 and has held it in 8 quarters since.
  • Zimmer Partners's PACS Group position peaked at $93.1M in Q3 2024.
  • 215 funds tracked by Wall St. Rank held PACS Group as of Q1 2026.

Based on Zimmer Partners's 13F filing for Q1 2026, filed 15 May 2026.